Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia

Increased serum prostate-specific antigen (PSA) level is closely associated with prostate cancer; however, there is still no reliable method for distinguishing prostate cancer from benign prostatic hyperplasia (BPH) when the PSA level is between 4 and 10 ng/mL. In this study, we detected the inflamm...

Full description

Bibliographic Details
Main Authors: Yuanyuan Guo, Beibei Liu, Jianmin Liu, Sheng Wang, Rui Wang, Rui Chang, Wenyan Sun, Tantu Ma, Qingwen Li
Format: Article
Language:English
Published: SAGE Publishing 2018-11-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/2058739218812665
_version_ 1818056766046339072
author Yuanyuan Guo
Beibei Liu
Jianmin Liu
Sheng Wang
Rui Wang
Rui Chang
Wenyan Sun
Tantu Ma
Qingwen Li
author_facet Yuanyuan Guo
Beibei Liu
Jianmin Liu
Sheng Wang
Rui Wang
Rui Chang
Wenyan Sun
Tantu Ma
Qingwen Li
author_sort Yuanyuan Guo
collection DOAJ
description Increased serum prostate-specific antigen (PSA) level is closely associated with prostate cancer; however, there is still no reliable method for distinguishing prostate cancer from benign prostatic hyperplasia (BPH) when the PSA level is between 4 and 10 ng/mL. In this study, we detected the inflammatory cell counts in serum and prostate tissues in prostate cancer and BPH patients. The results showed that the monocyte counts in both serum and prostate tissues were obviously less in patients with prostate cancer than that in those with BPH, which indicates that monocyte may be associated with development of prostate cancer and it is possible to increase positive finding for prostate cancer with 4–10 ng/mL PSA concentration by detecting and analyzing monocyte count in serum and tissue simultaneously.
first_indexed 2024-12-10T12:34:03Z
format Article
id doaj.art-4527111153154823ab9677a5d0c6f580
institution Directory Open Access Journal
issn 2058-7392
language English
last_indexed 2024-12-10T12:34:03Z
publishDate 2018-11-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-4527111153154823ab9677a5d0c6f5802022-12-22T01:48:43ZengSAGE PublishingEuropean Journal of Inflammation2058-73922018-11-011610.1177/2058739218812665Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasiaYuanyuan Guo0Beibei Liu1Jianmin Liu2Sheng Wang3Rui Wang4Rui Chang5Wenyan Sun6Tantu Ma7Qingwen Li8Department of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Medical Oncology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaDepartment of Urology, First Affiliated Hospital of Bengbu Medical College, Bengbu, ChinaIncreased serum prostate-specific antigen (PSA) level is closely associated with prostate cancer; however, there is still no reliable method for distinguishing prostate cancer from benign prostatic hyperplasia (BPH) when the PSA level is between 4 and 10 ng/mL. In this study, we detected the inflammatory cell counts in serum and prostate tissues in prostate cancer and BPH patients. The results showed that the monocyte counts in both serum and prostate tissues were obviously less in patients with prostate cancer than that in those with BPH, which indicates that monocyte may be associated with development of prostate cancer and it is possible to increase positive finding for prostate cancer with 4–10 ng/mL PSA concentration by detecting and analyzing monocyte count in serum and tissue simultaneously.https://doi.org/10.1177/2058739218812665
spellingShingle Yuanyuan Guo
Beibei Liu
Jianmin Liu
Sheng Wang
Rui Wang
Rui Chang
Wenyan Sun
Tantu Ma
Qingwen Li
Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
European Journal of Inflammation
title Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
title_full Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
title_fullStr Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
title_full_unstemmed Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
title_short Serum and tissue monocyte differentiation in PSA value 4–10 ng/mL prostate cancer and benign prostatic hyperplasia
title_sort serum and tissue monocyte differentiation in psa value 4 10 ng ml prostate cancer and benign prostatic hyperplasia
url https://doi.org/10.1177/2058739218812665
work_keys_str_mv AT yuanyuanguo serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT beibeiliu serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT jianminliu serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT shengwang serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT ruiwang serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT ruichang serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT wenyansun serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT tantuma serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia
AT qingwenli serumandtissuemonocytedifferentiationinpsavalue410ngmlprostatecancerandbenignprostatichyperplasia